Search

everythinglearnresearchcommunity

for

Search:↓

A multidisciplinary approach is crucial for effectively managing hair loss linked to endocrine and gynecological disorders.

The study aims to understand the skin and hair characteristics of mothers and their babies, and how these may affect newborns' skin health and mothers' postpartum hair loss.

Postpartum hair loss usually stops within 4-6 months.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

The conclusion is that three signs can help diagnose hair loss after it happens, potentially avoiding more invasive tests.

Babies born after 38 weeks to mothers under 36 years old and not delivered by C-section have a higher risk of neonatal occipital alopecia.

Menopause can cause hair loss in women due to hormonal changes, affecting their well-being and quality of life.

Diffuse hair loss in women is often linked to anemia, thyroid issues, and conditions like polycystic ovarian disease.

Many adult women experience unexplained excessive hair shedding, often starting before age 40.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Pregnancy can cause more body and scalp hair growth and make nails brittle, but these changes often revert after giving birth.

Pregnancy often causes skin changes like darkening, stretch marks, and hair growth, which may improve after childbirth.

Pregnancy can cause skin darkening, varicose veins, more sweating, hair growth, hair loss after birth, nail changes, and gum inflammation.

Pregnancy can cause normal skin changes that usually go away after childbirth and don't need treatment.

Doctors often miss Hair Tourniquet Syndrome, which can lead to serious damage if not treated quickly.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

ATE is linked to FAA, and treatment depends on cause; minoxidil helps, finasteride may worsen.

People with chronic hair loss may have a higher chance of Vitamin B12 deficiency.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Diffuse telogen alopecia is temporary hair loss treated by addressing the root cause and improving scalp health.

The document concludes that treating the underlying causes of telogen effluvium usually results in hair regrowth.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.